comparemela.com

Latest Breaking News On - Howardw robin - Page 1 : comparemela.com

Howard W. Robin Sells 16,650 Shares of Nektar Therapeutics (NASDAQ:NKTR) Stock

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) CEO Howard W. Robin sold 16,650 shares of Nektar Therapeutics stock in a transaction that occurred on Friday, May 17th. The shares were sold at an average price of $1.75, for a total transaction of $29,137.50. Following the sale, the chief executive officer now directly owns 863,239 shares […]

Florida
United-states
William-blair
Howardw-robin
Nasdaq
Mackenzie-financial-corp
Board-of-administration-florida-retirement-system
Marquette-asset-management
Jefferies-financial-group
Sg-americas-securities
Citigroup-inc
Nektar-therapeutics

Howard W. Robin Sells 19,998 Shares of Nektar Therapeutics (NASDAQ:NKTR) Stock

Howard W. Robin Sells 19,998 Shares of Nektar Therapeutics (NASDAQ:NKTR) Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states
Howardw-robin
Securities-exchange-commission
York-mellon-corp
Commonwealth-of-pennsylvania-public-school-empls-retrmt
Nasdaq
Dimensional-fund-advisors
Vanguard-group-inc
Jefferies-financial-group
Nektar-therapeutics
Get-free-report

Howard W. Robin Sells 19,998 Shares of Nektar Therapeutics (NASDAQ:NKTR) Stock

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) CEO Howard W. Robin sold 19,998 shares of the business’s stock in a transaction on Wednesday, August 16th. The shares were sold at an average price of $0.78, for a total transaction of $15,598.44. Following the completion of the transaction, the chief executive officer now directly owns 919,799 […]

Ohio
United-states
Hong-kong
Howardw-robin
First-citizens-bank-trust-co
Jefferies-financial-group
Nektar-therapeutics
Goldman-sachs-group-inc
Y-intercept-hong-kong-ltd
Nektar-therapeutics-company-profile
Get-free-report

Insider Selling: Nektar Therapeutics (NASDAQ:NKTR) CEO Sells 19,998 Shares of Stock

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) CEO Howard W. Robin sold 19,998 shares of the business’s stock in a transaction dated Wednesday, August 16th. The shares were sold at an average price of $0.78, for a total value of $15,598.44. Following the completion of the transaction, the chief executive officer now owns 919,799 shares […]

United-states
Howardw-robin
Nasdaq
Tower-research-capital
Nektar-therapeutics
Jefferies-financial-group
Securities-exchange-commission
Syntax-advisors
Envestnet-asset-management-inc
Life-insurance-co
Get-free-report

Nektar Therapeutics Reports Second Quarter 2023 Financial Results

/PRNewswire/ Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the second quarter ended June 30, 2023. Cash and investments in.

United-states
Alabama
California
San-francisco
David-rosen
Vivian-wu
Howardw-robin
Nektar-therapeutics
Merck-kga
Eli-lilly-co
Merck-kgaa
Exchange-commission-on

vimarsana © 2020. All Rights Reserved.